Quaratusugene ozeplasmid consists of non-viral lipid nanoparticles that encapsulate a DNA plasmid containing TUSC2, a tumor suppressor gene that is decreased in 82% of patients with NSCLC. Here, TUSC2 is linked to non-small cell lung carcinoma.